{"id":7033,"date":"2021-01-27T16:09:18","date_gmt":"2021-01-27T15:09:18","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=7033"},"modified":"2021-05-20T10:27:43","modified_gmt":"2021-05-20T09:27:43","slug":"luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/","title":{"rendered":"L&#8217;Universit\u00e9 d&#8217;Oxford a re\u00e7u 112 millions d&#8217;euros d&#8217;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques"},"content":{"rendered":"\n<p>Source de l&#8217;article : AFP, <a href=\"https:\/\/lematin.ma\/express\/2021\/luniversite-oxford-renforce-recherche-resistance-aux-antibiotiques\/351594.html\" target=\"_blank\" rel=\"noreferrer noopener\">LE MATIN&nbsp;19 janvier 2021 \u00e0 12:35<\/a><\/p>\n\n\n\n<p>L&#8217;Universit\u00e9 d&#8217;Oxford a annonc\u00e9 mardi avoir re\u00e7u un don de 100 millions de livres (112 millions d&#8217;euros), l&#8217;un des plus importants de son histoire, pour financer la recherche contre le probl\u00e8me croissant de la r\u00e9sistance aux antibiotiques.<\/p>\n\n\n\n<p>Ce financement apport\u00e9 par le g\u00e9ant de la chimie <a href=\"https:\/\/www.ineos.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">INEOS<\/a> sera utilis\u00e9 pour cr\u00e9er un institut destin\u00e9 \u00e0 d\u00e9velopper de nouveaux m\u00e9dicaments pour les animaux et les humains, ainsi qu&#8217;\u00e0 promouvoir une utilisation plus responsable des antibiotiques.<br><br>La r\u00e9sistance aux antibiotiques, provoqu\u00e9e par une utilisation excessive ou un mauvais usage des antibiotiques, rend les infections courantes plus difficiles \u00e0 traiter et augmente le risque de propagation des maladies, de formes graves des infections et de d\u00e9c\u00e8s.<br><br>En novembre, le chef de l&#8217;OMS, Tedros Adhanom GHEBREYESUS avait soulign\u00e9 que &#8220;la r\u00e9sistance aux antimicrobiens ne semble peut-\u00eatre pas aussi urgente qu&#8217;une pand\u00e9mie, mais elle est tout aussi dangereuse&#8221;. Elle constitue &#8220;l&#8217;une des plus grandes menaces sanitaires de notre temps&#8221; qui &#8220;menace de r\u00e9duire \u00e0 n\u00e9ant un si\u00e8cle de progr\u00e8s m\u00e9dical et de nous laisser sans d\u00e9fense contre des infections qui, aujourd&#8217;hui, peuvent \u00eatre trait\u00e9es facilement&#8221;, a-t-il pr\u00e9venu.<br><br>D&#8217;ici 2050, jusqu&#8217;\u00e0 10 millions de personnes risquent de mourir chaque ann\u00e9e \u00e0 cause de cette r\u00e9sistance.<\/p>\n\n\n\n<p>English version on the INEOS website: <a href=\"https:\/\/www.ineos.com\/news\/ineos-group\/ineos-donates-100-million-to-create-new-oxford-university-institute-to-fight-antimicrobial-resistance\/\" target=\"_blank\" rel=\"noreferrer noopener\">&#8220;INEOS donates \u00a3100 Million to create new Oxford University Institute to fight Antimicrobial Resistance&#8221;.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Source de l&#8217;article : AFP, LE MATIN&nbsp;19 janvier 2021 \u00e0 12:35 L&#8217;Universit\u00e9 d&#8217;Oxford a annonc\u00e9 mardi avoir re\u00e7u un don de 100 millions de livres (112 millions d&#8217;euros), l&#8217;un des plus importants de son histoire, pour financer la recherche contre le probl\u00e8me croissant de la r\u00e9sistance aux antibiotiques. Ce financement apport\u00e9 par le g\u00e9ant de [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":7037,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;Universit\u00e9 d&#039;Oxford a re\u00e7u 112 millions d&#039;euros d&#039;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;Universit\u00e9 d&#039;Oxford a re\u00e7u 112 millions d&#039;euros d&#039;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-27T15:09:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-20T09:27:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"757\" \/>\n\t<meta property=\"og:image:height\" content=\"621\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"L&#8217;Universit\u00e9 d&#8217;Oxford a re\u00e7u 112 millions d&#8217;euros d&#8217;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques\",\"datePublished\":\"2021-01-27T15:09:18+00:00\",\"dateModified\":\"2021-05-20T09:27:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\"},\"wordCount\":260,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\",\"name\":\"L'Universit\u00e9 d'Oxford a re\u00e7u 112 millions d'euros d'INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg\",\"datePublished\":\"2021-01-27T15:09:18+00:00\",\"dateModified\":\"2021-05-20T09:27:43+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg\",\"width\":757,\"height\":621,\"caption\":\"Universit\u00e9 d'Oxford (Cr\u00e9dit : Pixabay)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"L&#8217;Universit\u00e9 d&#8217;Oxford a re\u00e7u 112 millions d&#8217;euros d&#8217;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'Universit\u00e9 d'Oxford a re\u00e7u 112 millions d'euros d'INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/","og_locale":"en_GB","og_type":"article","og_title":"L'Universit\u00e9 d'Oxford a re\u00e7u 112 millions d'euros d'INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2021-01-27T15:09:18+00:00","article_modified_time":"2021-05-20T09:27:43+00:00","og_image":[{"width":757,"height":621,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"L&#8217;Universit\u00e9 d&#8217;Oxford a re\u00e7u 112 millions d&#8217;euros d&#8217;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques","datePublished":"2021-01-27T15:09:18+00:00","dateModified":"2021-05-20T09:27:43+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/"},"wordCount":260,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/","name":"L'Universit\u00e9 d'Oxford a re\u00e7u 112 millions d'euros d'INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg","datePublished":"2021-01-27T15:09:18+00:00","dateModified":"2021-05-20T09:27:43+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/Univ-Oxford.jpg","width":757,"height":621,"caption":"Universit\u00e9 d'Oxford (Cr\u00e9dit : Pixabay)"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/luniversite-doxford-a-recu-112-millions-deuros-dineos-pour-renforcer-la-recherche-sur-la-resistance-aux-antibiotiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"L&#8217;Universit\u00e9 d&#8217;Oxford a re\u00e7u 112 millions d&#8217;euros d&#8217;INEOS pour renforcer la recherche sur la r\u00e9sistance aux antibiotiques"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-17 12:18:10","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/7033"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=7033"}],"version-history":[{"count":15,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/7033\/revisions"}],"predecessor-version":[{"id":7107,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/7033\/revisions\/7107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/7037"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=7033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=7033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=7033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}